Literature DB >> 20306284

A computational workflow for the design of irreversible inhibitors of protein kinases.

Alberto Del Rio1, Miriam Sgobba, Marco Daniele Parenti, Gianluca Degliesposti, Rosetta Forestiero, Claudia Percivalle, Pier Franco Conte, Mauro Freccero, Giulio Rastelli.   

Abstract

Design of irreversible inhibitors is an emerging and relatively less explored strategy for the design of protein kinase inhibitors. In this paper, we present a computational workflow that was specifically conceived to assist such design. The workflow takes the form of a multi-step procedure that includes: the creation of a database of already known reversible inhibitors of protein kinases, the selection of the most promising scaffolds that bind one or more desired kinase templates, the modification of the scaffolds by introduction of chemically reactive groups (suitable cysteine traps) and the final evaluation of the reversible and irreversible protein-ligand complexes with molecular dynamics simulations and binding free energy predictions. Most of these steps were automated. In order to prove that this is viable, the workflow was tested on a database of known inhibitors of ERK2, a protein kinase possessing a cysteine in the ATP site. The modeled ERK2-ligand complexes and the values of the estimated binding free energies of the putative ligands provide useful indicators of their aptitude to bind reversibly and irreversibly to the protein kinase. Moreover, the computational data are used to rank the ligands according to their computed binding free energies and their ability to bind specific protein residues in the reversible and irreversible complexes, thereby providing a useful decision-making tool for each step of the design. In this work we present the overall procedure and the first proof of concept results.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20306284     DOI: 10.1007/s10822-010-9324-x

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  33 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  Development and testing of a general amber force field.

Authors:  Junmei Wang; Romain M Wolf; James W Caldwell; Peter A Kollman; David A Case
Journal:  J Comput Chem       Date:  2004-07-15       Impact factor: 3.376

Review 3.  Tyrosine kinases as targets for cancer therapy.

Authors:  Daniela S Krause; Richard A Van Etten
Journal:  N Engl J Med       Date:  2005-07-14       Impact factor: 91.245

Review 4.  Are MAP kinases drug targets? Yes, but difficult ones.

Authors:  Simona Margutti; Stefan A Laufer
Journal:  ChemMedChem       Date:  2007-08       Impact factor: 3.466

5.  Rapid estimation of relative protein-ligand binding affinities using a high-throughput version of MM-PBSA.

Authors:  Scott P Brown; Steven W Muchmore
Journal:  J Chem Inf Model       Date:  2007-05-23       Impact factor: 4.956

6.  Rapid and accurate prediction of binding free energies for saquinavir-bound HIV-1 proteases.

Authors:  Ileana Stoica; S Kashif Sadiq; Peter V Coveney
Journal:  J Am Chem Soc       Date:  2008-01-29       Impact factor: 15.419

Review 7.  Covalent modifiers: an orthogonal approach to drug design.

Authors:  Michele H Potashman; Mark E Duggan
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

8.  Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA.

Authors:  Giulio Rastelli; Alberto Del Rio; Gianluca Degliesposti; Miriam Sgobba
Journal:  J Comput Chem       Date:  2010-03       Impact factor: 3.376

9.  Validation and use of the MM-PBSA approach for drug discovery.

Authors:  Bernd Kuhn; Paul Gerber; Tanja Schulz-Gasch; Martin Stahl
Journal:  J Med Chem       Date:  2005-06-16       Impact factor: 7.446

10.  Jalview Version 2--a multiple sequence alignment editor and analysis workbench.

Authors:  Andrew M Waterhouse; James B Procter; David M A Martin; Michèle Clamp; Geoffrey J Barton
Journal:  Bioinformatics       Date:  2009-01-16       Impact factor: 6.937

View more
  2 in total

1.  Discovery of Lysine-Targeted eIF4E Inhibitors through Covalent Docking.

Authors:  Xiaobo Wan; Tangpo Yang; Adolfo Cuesta; Xiaming Pang; Trent E Balius; John J Irwin; Brian K Shoichet; Jack Taunton
Journal:  J Am Chem Soc       Date:  2020-03-04       Impact factor: 15.419

2.  Automated computational screening of the thiol reactivity of substituted alkenes.

Authors:  Jennifer M Smith; Christopher N Rowley
Journal:  J Comput Aided Mol Des       Date:  2015-07-10       Impact factor: 3.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.